| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $243.2M | +3.4% |
| Cost of Revenue | $68.6M | -11.4% |
| Gross Profit | $174.6M | +10.7% |
| R&D Expense | $32.4M | -15.6% |
| SG&A Expense | $46.0M | -21.0% |
| Operating Income | $44.8M | +255.2% |
| Pre-tax Income | $46.5M | +270.2% |
| Income Tax | -$10.6M | -526.2% |
| Net Income | $57.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.2M | +95.7% |
| Accounts Receivable | $56.2M | -12.7% |
| Inventory | $10.8M | -30.6% |
| Current Assets | $175.1M | +19.6% |
| Total Assets | $338.7M | +17.1% |
| Current Liabilities | $110.3M | -4.0% |
| Total Liabilities | $126.2M | -3.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $55.7M | +618.6% |
| Capital Expenditures | $9.2M | -25.9% |
| Investing Cash Flow | -$9.3M | +22.5% |
| Financing Cash Flow | -$5.2M | +83.7% |
| Free Cash Flow | $46.4M | +299.9% |
| +291.6% |
| EPS (Basic) | $1.49 | +301.4% |
| EPS (Diluted) | $1.46 | +297.3% |
| Stockholders' Equity |
| $212.5M |
| +33.5% |